Top 10 Key Players companies in PCSK9 Inhibitors by Most Literature Citation in the United States in 2018 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Literature Citation PCSK9 Inhibitors Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Literature citation: 215
2	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Literature citation: 51
3	Esperion Therapeutics, Inc.	Michigan, United States	Medicine,Health care,Cardiovascular agent, ...[+2]	Literature citation: 37
4	Medpace, Inc.	Ohio, United States	Clinical research,Drug discovery,Contract research organization, ...[+2]	Literature citation: 31
5	Beth Israel Deaconess Medical Center, Inc.	Massachusetts, United States	Medical school,Clinical research,Health care, ...[+2]	Literature citation: 25
6	Cardiovascular Institute of the South	Louisiana, United States	Vascular Medicine,Health care,Lipid management, ...[+2]	Literature citation: 21
7	Baptist Hospital of Miami, Inc.	United States	Physician self-referral,Health care,Hospitality industry, ...[+2]	Literature citation: 21
8	Datamonitor, Inc.	New York, United States	Operational decision,Market intelligence,Data analysis, ...[+1]	Literature citation: 5
9	Memorial Hospital & Health System	Indiana, United States	Health care,Hospitality industry,Childbirth, ...[+2]	Literature citation: 5
10	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Literature citation: 1